[期刊]
  • 《Pharmacogenetics and genomics》 2023年33卷2期

摘要 : ObjectiveTo evaluate Chinese long-term economic impact of universal human leukocyte antigen B (HLA-B)*58:01 genotyping-guided urate-lowering therapy or febuxostat initiation therapy for gout patients with mild to moderate chronic ... 展开

相关作者
相关关键词